Baosheng Science and Technology Innovation (600973) Fundamentals 2026 — Revenue Analysis | SniperIQ
Baosheng Science and Technology Innovation (600973) is a CN-listed Industrials company in Electrical Equipment & Parts with a market capitalization of ¥7.5B, trading at ¥5.50 on the SHH. This SniperIQ fundamentals page covers Baosheng Science and Technology Innovation's valuation, profitability (net margin -0.0%), revenue (¥47.9B in FY2025), balance-sheet quality, and AI signal context — from live market data, research only.
Full research coverage
- 8-Quarter Revenue & Margin Trend
- Debt Maturity & Coverage
- Peer Valuation Comparison
- Free Cash Flow & Owner Earnings
- AI Signal + Institutional Flow
- DCF Valuation Model
Frequently Asked Questions
What is Baosheng Science and Technology Innovation's market cap?
Baosheng Science and Technology Innovation (600973) has a market capitalization of approximately ¥7.5B, trading at ¥5.50 on the SHH. Market cap moves with the live share price.
What is Baosheng Science and Technology Innovation's P/E ratio?
Baosheng Science and Technology Innovation's trailing twelve-month P/E ratio is not meaningful (negative or nil earnings), with a price-to-book (P/B) of 2.2x. Valuation multiples are best compared with Industrials sector peers rather than read in isolation.
How profitable is Baosheng Science and Technology Innovation?
Baosheng Science and Technology Innovation runs a net profit margin of -0.0%, a gross margin of 3.9%, and an operating margin of 0.2%. Margins and ROE indicate how efficiently the business converts sales into profit and shareholder returns.
How much revenue does Baosheng Science and Technology Innovation generate?
Baosheng Science and Technology Innovation reported revenue of ¥47.9B for fiscal year 2025, with net income of -¥44M and earnings per share (EPS) of -0.032. SniperIQ tracks the full 8-quarter revenue and margin trend on the research dashboard.
Does Baosheng Science and Technology Innovation pay a dividend?
Baosheng Science and Technology Innovation does not currently show a material trailing dividend yield; it is positioned more as a total-return name. Always confirm the latest dividend policy in the company's filings.
Is Baosheng Science and Technology Innovation financially healthy?
Baosheng Science and Technology Innovation carries a debt-to-equity ratio of 3.17x and a current ratio of 1.06x, with a market beta of 0.13. Lower leverage and a current ratio above 1.0 generally signal a stronger balance sheet.
Is Baosheng Science and Technology Innovation a good stock to buy in 2026?
SniperIQ provides research-only market intelligence, not personalised financial advice or a buy/sell call. For Baosheng Science and Technology Innovation (600973) the key facts are: market cap ¥7.5B, revenue ¥47.9B, 52-week range 5-9.38. Weigh valuation, profitability, growth, and balance-sheet strength against Industrials peers and form your own view.
Track Baosheng Science and Technology Innovation's full fundamentals live
Get Baosheng Science and Technology Innovation's 8-quarter revenue and margin trend, peer comparison, DCF model, and AI signal on the SniperIQ research dashboard.